TY - JOUR
T1 - The Effect of Aspirin use following Woven EndoBridge Treatment
T2 - A Multicenter Study with Propensity Score-Matching
AU - Musmar, Basel
AU - Salim, Hamza Adel
AU - Roy, Joanna M.
AU - Adeeb, Nimer
AU - Fuleihan, Antony A.
AU - Atallah, Elias
AU - El Baba, Bachar
AU - Howard, Brian M.
AU - Grossberg, Jonathan A.
AU - Scott, Kyle W.
AU - Burkhardt, Jan Karl
AU - Srinivasan, Visish M.
AU - Erazu, Fernanda
AU - Sauvageau, Eric
AU - Aghaebrahim, Amin
AU - Hanel, Ricardo A.
AU - Amllay, Abdelaziz
AU - Matouk, Charles
AU - Macneil, Andrew
AU - Chalouhi, Nohra
AU - Koch, Matthew
AU - Gomez-Paz, Santiago
AU - Grandhi, Ramesh
AU - Jaikumar, Vinay
AU - Levy, Elad
AU - Siddiqui, Adnan
AU - Kayan, Yasha
AU - Copelan, Alexander Z.
AU - Delgado Almandoz, Josser E.
AU - Hoffman, Haydn
AU - Arthur, Adam
AU - Hasan, David M.
AU - Notarianni, Christina
AU - Cuellar, Hugo H.
AU - Guthikonda, Bharat
AU - Morcos, Jacques
AU - Tjoumakaris, Stavropoula I.
AU - Gooch, Michael Reid
AU - Rosenwasser, Robert H.
AU - Jabbour, Pascal
N1 - Publisher Copyright:
© The Author(s), 2026. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation.
PY - 2026
Y1 - 2026
N2 - Background: The Woven EndoBridge (WEB) device has emerged as a promising option for treating wide-neck bifurcation aneurysms. This multicenter study aimed to evaluate the impact of postoperative aspirin (ASA) use on clinical and angiographic outcomes in patients treated with the WEB device. Methods: We conducted a retrospective multicenter study across 10 academic institutions, analyzing patients with ruptured or unruptured intracranial aneurysms treated with the WEB device. Results: A total of 225 patients were included, with 163 (72.4%) receiving postoperative ASA and 62 (27.6%) in the No AP group. Before PSM, the ASA group demonstrated significantly higher rates of excellent functional outcomes (mRS 0-1: 84% vs. 70%, p = 0.031) and lower mortality (3.3% vs. 13%, p=0.014). Retreatment rates were also significantly lower in the ASA group (8.6% vs. 23%, p = 0.005). After PSM, 120 patients remained (74 ASA, 46 No AP).Retreatment rates remained significantly lower in the ASA group (5.4% vs. 24%, p=0.003), whereas the other outcomes did not reach statistical significance after matching. Conclusion: Postoperative aspirin use following WEB device treatment for intracranial aneurysms was associated with significantly lower retreatment rates, without compromising functional outcomes or mortality rates. These findings support the potential role of aspirin in enhancing aneurysm stability. Further prospective studies are needed to confirm.
AB - Background: The Woven EndoBridge (WEB) device has emerged as a promising option for treating wide-neck bifurcation aneurysms. This multicenter study aimed to evaluate the impact of postoperative aspirin (ASA) use on clinical and angiographic outcomes in patients treated with the WEB device. Methods: We conducted a retrospective multicenter study across 10 academic institutions, analyzing patients with ruptured or unruptured intracranial aneurysms treated with the WEB device. Results: A total of 225 patients were included, with 163 (72.4%) receiving postoperative ASA and 62 (27.6%) in the No AP group. Before PSM, the ASA group demonstrated significantly higher rates of excellent functional outcomes (mRS 0-1: 84% vs. 70%, p = 0.031) and lower mortality (3.3% vs. 13%, p=0.014). Retreatment rates were also significantly lower in the ASA group (8.6% vs. 23%, p = 0.005). After PSM, 120 patients remained (74 ASA, 46 No AP).Retreatment rates remained significantly lower in the ASA group (5.4% vs. 24%, p=0.003), whereas the other outcomes did not reach statistical significance after matching. Conclusion: Postoperative aspirin use following WEB device treatment for intracranial aneurysms was associated with significantly lower retreatment rates, without compromising functional outcomes or mortality rates. These findings support the potential role of aspirin in enhancing aneurysm stability. Further prospective studies are needed to confirm.
UR - https://www.scopus.com/pages/publications/105036077502
U2 - 10.1017/cjn.2026.10600
DO - 10.1017/cjn.2026.10600
M3 - Article
AN - SCOPUS:105036077502
SN - 0317-1671
JO - Canadian Journal of Neurological Sciences
JF - Canadian Journal of Neurological Sciences
ER -